Poker Power x IFW $100,000 "Power Play" Small Business Grant

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

Purpose: The Department of Resources Recycling and Recovery (CalRecycle) offers the Beverage Container Redemption Innovation Grant Program pursuant to Senate Bill (SB) 101 (Chapter 12, Skinner, Budget Act of 2023). The purpose of the grant is to provide funding for reverse vending machines for Dealers to meet requirements of Public Resources Code 14578 (a)(1), commonly referred to as Option 1. Description: Eligible applicants include: Dealers. A retail establishment in an unserved convenience zone which offers the sale of beverages in beverage containers to consumers that is required to redeem in-store (Option 1). These entities are not required to be certified as a recycling center. All Dealers must submit an affidavit to CalRecycle that states they choose to redeem in-store prior to the issuance of the Notice to Proceed (NTP) email. Dealers must be registered through the Dealer Registration and Management System (DReaMS) prior to submission of the application.

Golden Mussels (Limnoperna fortunei) are an aquatic freshwater/brackish invasive bivalve species first discovered in California"s Sacramento-San Joaquin Delta (Delta) on October 2024. This discovery is the first known occurrence of golden mussel in North America and was likely introduced to California via ballast water from a commercial ship traveling from an international port. Now that Golden Mussel are present in the Delta, they can be easily transported via trailered watercraft to areas that have not yet been invaded. This Request for Proposals (RFP) will fund projects in the listed principle areas of the Western United States towards the fulfillment of the top priorities similar to those identified in the State of California"s Golden Mussel Response Framework (April 14, 2025).

digitalundivided's BREAKTHROUGH Program, sponsored by JPMorgan Chase & Co, provides founders with a deeper understanding of their customers, startup funding, growth marketing strategies, and networking opportunities to scale their ventures. Each company accepted into the program will receive a $5,000 grant.

This Notice of Funding Opportunity (NOFO) aims to support new biomedical, behavioral, and social science investigators who are in the early stages of establishing independent careers in tobacco regulatory research. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, and development of new research technology. Applicants are encouraged to conduct projects that ultimately have the potential to inform regulations on tobacco product manufacturing, distribution, and marketing. Research projects must address one or more High-Priority Research Topic(s) related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this NOFO will be administered by NIH using funds made available through FDA CTP and the FSPTCA. Research results from this NOFO are expected to generate findings and data directly relevant to informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.